Meeting list

The second national symposium on genetic diseases diagnosis and eugenics consultation and the national academic forum on birth defect prevention and eugenics closed

Inputtime:2016-06-07 15:53:00 Views:
On the morning of June 4th, the second national academic seminar on prenatal diagnosis and eugenics consultation, namely the academic forum on birth defect prevention and genetic eugenics, sponsored by China eugenics science association and hosted by jinan maternal and child health hospital, was held in jinan, beautiful spring city.
 
This meeting is mainly in order to further strengthen academic exchanges in the field of birth defect prevention and control, improve the workers, the basic theory and technical skills, at the same time in order to further promote eugenics science and maternal and child health care continued to flourish, to better implement the "law of the People's Republic of China, law on maternal and infant health care, the measures for prenatal diagnosis technology management and improve the quality of birth population.
The BBS invite domestic prenatal diagnosis, birth defect prevention, medical genetics, obstetric emergency and severe cases treatment of famous experts, the chromosome disease, genetic metabolic disease, poor fertility history to have guidance, rare disease genetic testing, noninvasive fetal DNA detection, B ultra soft data, obstetric treatment for critical patients, newborn metabolic disease gene diagnosis and application of magnetic resonance in obstetric industry concerned about hot spots for centralized teaching and academic exchanges.
Many authoritative experts in the field of domestic eugenics attended the meeting, including bian xuming, zhu jun, gu xuefan, wang xietong and other experts and professors, and nearly 400 medical workers from all over the country attended the meeting.
 
At the meeting, Mr. Miaoyuan of yingsheng biology made a special report on "clinical application of gene detection and mass spectrometry platform", which introduced in detail the application program of genetic deafness gene detection project, neonatal genetic and metabolic disease screening project and vitamin 14 test project in prenatal diagnosis and prevention of birth defects.
 
 
 
Genetic deafness gene detection project adopts fluorescence PCR method to detect and intervene congenital deafness, delayed deafness and drug-induced deafness effectively to avoid birth defects through screening before and during pregnancy and combined with hearing loss screening of newborn deafness genes.
The screening program of genetic and metabolic diseases of newborn adopts tandem mass spectrometry, which can screen 45 kinds of genetic and metabolic diseases through one blood tablet of newborn, so as to achieve early detection, early diagnosis and early treatment, further reduce birth defects and save more children.
The 14 vitamin detection items adopted tandem mass spectrometry, through a single experiment can quickly detect the content of 14 vitamins, accurate determination, accurate supplement, so as to achieve the goal of good birth and good breeding.
Ying sheng biology has grown up in two major gene detection and mass spectrometry platform, on the basis of the two big platform with independent innovation technology successfully developed the deafness gene diagnosis kit series products, the item 45 genetic metabolic disease diagnosis reagent, 14 vitamins determination reagent products, as well as the relevant supporting software, products and software for the domestic initiative, the international lead.
The product has successfully passed the clinical trial and obtained the registration certificate issued by the state food and drug administration (CFDA).